Product Information

DYMISTA NASAL SPRAY is a brand product labeled by Viatris Specialty LLC, priced at $9.0945 per GM under NDC 00037024523. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Azelastine Hydrochloride and Fluticasone Propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

High Outlier

Strength

137; 50 ug/1; ug/1

NDC

00037024523

Classification

Brand

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA202236

FDA Approved

5/1/2012

TE Code

AB

On Market Since

10/1/2016

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for DYMISTA NASAL SPRAY has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 55.7%. The table below summarizes its recorded NADAC range and movement.

Current price$9.0945 per GM
All-time high$9.1784 (Oct 15, 2025)
All-time low$5.8239 (Mar 19, 2014)
52-week high$9.1507
52-week low$9.0945
Median price$8.3313
Average price$7.9645
Largest weekly change+10.0% (Jan 21, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.5%

3M

-0.5%

6M

-0.6%

1Y

-0.6%

3Y

+4.3%

5Y

+9.2%

All

+55.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DYMISTA NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for DYMISTA NASAL SPRAY, manufactured by Viatris Specialty LLC, is $9.0945 per GM (NDC 00037024523), effective Nov 18, 2026.

How has the price of DYMISTA NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for DYMISTA NASAL SPRAY has risen 55.7%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DYMISTA NASAL SPRAY?

Since Nov 28, 2013, the NADAC for DYMISTA NASAL SPRAY has ranged from a low of $5.8239 (Mar 19, 2014) to a high of $9.1784 (Oct 15, 2025), with a median of $8.3313 per GM.

Are there cheaper alternatives to DYMISTA NASAL SPRAY?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZELASTIN-FLUTIC 137-50 MCG SPR, is $2.1480 per GM — about 76% below DYMISTA NASAL SPRAY.

Who manufactures DYMISTA NASAL SPRAY?

DYMISTA NASAL SPRAY (NDC 00037024523) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.